- Home
- NNOX vs ENGN Comparison
NNOX vs ENGN Comparison
Compare NNOX & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- ENGN
- Stock Information
- Founded
- NNOX 2011
- ENGN 1999
- Country
- NNOX Israel
- ENGN Canada
- Employees
- NNOX N/A
- ENGN N/A
- Industry
- NNOX Medical Electronics
- ENGN
- Sector
- NNOX Health Care
- ENGN
- Exchange
- NNOX Nasdaq
- ENGN Nasdaq
- Market Cap
- NNOX 302.9M
- ENGN 297.7M
- IPO Year
- NNOX 2020
- ENGN N/A
- Fundamental
- Price
- NNOX $5.24
- ENGN $2.96
- Analyst Decision
- NNOX Strong Buy
- ENGN Buy
- Analyst Count
- NNOX 2
- ENGN 7
- Target Price
- NNOX $12.00
- ENGN $23.29
- AVG Volume (30 Days)
- NNOX 900.4K
- ENGN 49.1K
- Earning Date
- NNOX 05-27-2025
- ENGN 06-13-2025
- Dividend Yield
- NNOX N/A
- ENGN N/A
- EPS Growth
- NNOX N/A
- ENGN N/A
- EPS
- NNOX N/A
- ENGN N/A
- Revenue
- NNOX $11,283,000.00
- ENGN N/A
- Revenue This Year
- NNOX $105.67
- ENGN N/A
- Revenue Next Year
- NNOX $177.95
- ENGN N/A
- P/E Ratio
- NNOX N/A
- ENGN N/A
- Revenue Growth
- NNOX 13.91
- ENGN N/A
- 52 Week Low
- NNOX $3.75
- ENGN $3.27
- 52 Week High
- NNOX $11.00
- ENGN $14.67
- Technical
- Relative Strength Index (RSI)
- NNOX 53.53
- ENGN 21.28
- Support Level
- NNOX $4.85
- ENGN $3.51
- Resistance Level
- NNOX $5.25
- ENGN $3.99
- Average True Range (ATR)
- NNOX 0.23
- ENGN 0.41
- MACD
- NNOX 0.05
- ENGN -0.04
- Stochastic Oscillator
- NNOX 72.73
- ENGN 1.38
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.